Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
08/2000
08/22/2000US6107281 Compounds and their combinations for the treatment of influenza infection
08/22/2000US6107280 Administering bactericidal/permeability-increasing protein to delay or prevent clot formation in the blood or to enhance clot dissolution in blood
08/22/2000US6107275 Anticoagulants
08/22/2000US6107274 Enzyme inhibitors as hypoglycemic agents in treatment of type-ii diabetes
08/22/2000US6107273 Tumor necrosis factor inhibitors
08/22/2000US6107272 Modified polypeptides with altered biological activity
08/22/2000US6107271 Neuroactive peptides
08/22/2000US6107094 In vitro modification of target rna by contacting solution of target and ribonuclease preferential for double-stranded rna with oligonucleotide complementary to target and including nucleotides modified to improve affinity/specificity
08/22/2000US6107092 Compound 8 to 30 nucleobases in length targeted to human steroid receptor rna activtor or nucleic acid encoding the activator; for decreased amount or function; therapy and prophylaxis of related diseases
08/22/2000US6107091 Compound 8 to 30 nucleobases in length targeted to 5' or 3' untranslated regions or coding region of a nucleic acid encoding human g protein; diagnosis, prophylaxis and therapy of related diseases
08/22/2000US6107090 Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
08/22/2000US6107089 Nucleic acids encoding annexin XI
08/22/2000US6107088 XAF genes and polypeptides: methods and reagents for modulating apoptosis
08/22/2000US6107075 Human elastase IV
08/22/2000US6107073 Kinase capable of site-specific phosphorylation of IκBα
08/22/2000US6107071 Polynucleotide or complementary sequence which codes for a specific staphylococcus aureus amino acid sequence; for diagnosis of bacterial infections; screening of bactericides, bacteriostats, and antibiotics
08/22/2000US6107070 Human manganese superoxide dismutase proteins
08/22/2000US6107062 Antisense viruses and antisense-ribozyme viruses
08/22/2000US6107041 Detecting modulators of inhibitor of apoptosis; incubating cell that expresses inhibitor of apoptosis with modulator, monitor the expression of inhibitor of apoptosis, increase in apoptosis is indicator of the presence of a modulator
08/22/2000US6107028 Prevention of viral replication or expression; insertion of a expression vector coding ribonucleic acid preferential proteolytic enzyme into cells infected with virus
08/22/2000US6107027 Supression of viral gene expression in cells; transducing cells with a adenovirus vector which codes a protein which has preferential proteolytic activity for ribonucleic acids
08/22/2000US6107019 Monitoring modulator of viral disease suppression; fixing chemokine receptor on solid matrix, incubation with modulator and glycoprotein complex, monitoring bound glycoprotein complex in presence of modulator
08/22/2000US6106874 Calcium fortified fruit beverages
08/22/2000US6106868 Method for the treatment of hepatitis
08/22/2000US6106860 Fatty ester of glycerol, diglycerol up to pentadecaglycerol as carriers for antibiotics
08/22/2000US6106858 Loading active materials of liposomes by dissolving
08/22/2000US6106844 Administering to venom allergic patient
08/22/2000US6106835 Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators
08/22/2000US6106834 Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
08/22/2000US6106833 Bispecific antibodies, methods of production and use thereof
08/22/2000US6106832 Treating x-linked hyper igm syndrome and combined variable immunodeficiency syndrome
08/22/2000US6106830 Methods for the treatment of apoptosis-related diseases by batroxobin
08/22/2000US6106829 Diagnostic cancer marker; hybridization; vaccines
08/22/2000US6106826 Replication competent, avirulent Herpes simplex virus as a vector for neural and ocular gene therapy
08/22/2000US6106824 Expression of growth associated protein B-50/GAP-43 in vitro and in vivo
08/22/2000US6106823 Treatment of neoplastic disease with interleukin-10
08/22/2000US6106822 Hormone and growth factor phosphoglycokine mimetics from mycobacterium
08/22/2000US6106805 Diagnostic composition containing an LH-RH antagonist for hysteroscopy
08/22/2000CA2194158C Desquamation compositions
08/22/2000CA2176494C Purification of hemoglobin
08/22/2000CA2168964C Novel peptide, and platelet aggregation-inhibiting agents, blood coagul ation-inhibiting agents for extracorporeal circulation, cell adhesion-inhibiting agents, tumor metastasis-inhibiting agents, agents for protecting platelet preparations for blood transfusion, platelet preparations and platelet preparation packs for transfusion using said novel peptides
08/22/2000CA2165992C Disulphides
08/22/2000CA2050343C Matrix metalloproteinase peptides: role in diagnosis and therapy
08/22/2000CA2046900C Melanin-concentrating hormones and methods of treatment using same
08/22/2000CA2031199C Antibacterial and antimalarial peptides
08/22/2000CA2018801C Antiherpes peptide derivatives having a 1,4-dioxo c n-terminus
08/22/2000CA2016627C Proteinase inhibitors, process for the preparation thereof and medicaments containing these
08/17/2000WO2000047757A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament
08/17/2000WO2000047743A1 Neisseria meningitidis serogroup b antigen
08/17/2000WO2000047741A1 Glycosylated leptin compositions and related methods
08/17/2000WO2000047736A1 Polypeptide variants with raised heparin-binding capacity
08/17/2000WO2000047735A2 NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
08/17/2000WO2000047734A1 Inhibiting formation of atherosclerotic lesions
08/17/2000WO2000047729A1 Deglycosylated kringle 1-5 region fragments of plasminogen and methods of use
08/17/2000WO2000047725A1 Nitroreductase enzymes
08/17/2000WO2000047723A2 Human diacylglycerol kinase beta (hdagk beta) proteins and nucleotide sequences encoding the same
08/17/2000WO2000047721A2 Methods of inducing insulin positive progenitor cells
08/17/2000WO2000047716A2 Fibres for culturing eukaryotic cells
08/17/2000WO2000047625A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000WO2000047624A1 Dihydroouabain-like factor and diagnostic and therapeutic compositions and methods
08/17/2000WO2000047623A1 Artificial peptides having surface activity and the use thereof in the preparation of artificial surfactant
08/17/2000WO2000047622A2 Peptides with anti-angiogenic activity
08/17/2000WO2000047620A1 Cytokine-binding domain
08/17/2000WO2000047619A1 Therapeutics and diagnostics based on an il-1b mutation
08/17/2000WO2000047618A2 HUMAN β-SECRETASE ENZYME, INHIBITORS AND THEIR COMPOSITIONS AND USES
08/17/2000WO2000047617A1 Human uncoupling proteins and polynucleotides encoding the same
08/17/2000WO2000047616A1 Tpaace06: human ptd016 gene
08/17/2000WO2000047615A2 Proteins related to neuronal regeneration and uses thereof
08/17/2000WO2000047611A2 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000WO2000047610A2 Method for altering undesirable immune responses to polypeptides
08/17/2000WO2000047609A1 Cyclic peptides and aids vaccines
08/17/2000WO2000047607A1 A synthetic peptide disturbing intracellular signaling
08/17/2000WO2000047606A1 Peptides inhibiting vascular endothelial cell migration
08/17/2000WO2000047605A2 Enterocyte growth factors and method for their isolation
08/17/2000WO2000047602A1 33 human secreted proteins
08/17/2000WO2000047563A1 LACTAM INHIBITORS OF FXa AND METHOD
08/17/2000WO2000047284A2 Novel use of orexin receptor antagonists
08/17/2000WO2000047240A1 Methods of inactivating pathogens using broad-spectrum pulsed light
08/17/2000WO2000047235A2 Methods of stimulating angiogenesis
08/17/2000WO2000047234A1 Sustained release salts of pharmaceutically active peptides and their production
08/17/2000WO2000047231A2 Novel antisense inhibition of rad51
08/17/2000WO2000047229A2 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000WO2000047228A1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
08/17/2000WO2000047223A2 Viral vaccine
08/17/2000WO2000047221A1 Antiangiogenic drugs
08/17/2000WO2000047220A1 Controlling protein levels in eucaryotic organisms
08/17/2000WO2000047219A2 Methods and reagents for treating glucose metabolic disorders
08/17/2000WO2000047218A1 Regulation of photoreceptor degeneration
08/17/2000WO2000047217A2 Protection of cells in connection with treatment with chemical agents
08/17/2000WO2000047216A1 Immunogenic compositions for use as vaccines
08/17/2000WO2000047214A1 Anti-resorptive bone cements and allogeneic, autografic, and xenografic bone grafts
08/17/2000WO2000047203A1 Formulation and system for intra-oral delivery of pharmaceutical agents
08/17/2000WO2000047195A1 Stimulating neutrophil function to treat inflammatory bowel disease
08/17/2000WO2000047188A1 Oxadiazole compounds and compositions for delivering active agents
08/17/2000WO2000047175A1 Oral compositions and methods of production thereof
08/17/2000WO2000047174A1 Compositions for controlling bacterial colonization
08/17/2000WO2000047148A1 Methods and compositions for enhancing fibroblast migration
08/17/2000WO2000047114A1 Injectable collagen-based delivery system for bone morphogenic proteins
08/17/2000WO2000047104A2 Antagonists of hmg1 for treating inflammatory conditions
08/17/2000WO2000047102A2 COMPOSITIONS AND METHODS FOR MODULATING TGF-β SIGNALING
1 ... 2356 2357 2358 2359 2360 2361 2362 2363 2364 2365 2366 2367 2368 2369 2370 2371 2372 2373 2374 2375 2376 ... 3163